Synthesis of RPR 100893, prototype of a new series of potent and selective non peptide NK1 antagonists : the triarylperhydroisoindolols.
The synthesis of RPR 100893, a non peptide substance P antagonist with higher affinity for human NK1 receptor is described.
References (19)
- et al.
Neurochem. Int.
(1991) - Achard D.; Grisoni, S.; Hanessian, S.; Moutonnier, C.; Peyronel, J.F.; Tabart, M., European Patents 514273 and 514274...
- Fardin, V.; Heuillet, E.; Carruette, A.; Blanchard, J-C.; Garret, C. submitted for...
- Moussaoui, S.M.; Montier, F.; Carruette, A.; Floch, A.; Blanchard, J-C.; Garret, C. submitted for...
- et al.
Annu. Rev. Neurosci.
(1980) - et al.
Trends Pharmacol. Sci.
(1987) - et al.
Pharmacol. Rev.
(1983)et al.Annu. Rev. Neurosci.
(1988)et al.J. Immunol.
(1984)et al.Nature
(1987) - (a) Lowe, III J.A., World patent WO... et al.
J. Med. Chem.
(1992)
There are more references available in the full text version of this article.
Cited by (46)
Synthesis and NK<inf>1</inf> receptor antagonistic activity of (+)-1-acyl-3-(3,4- dichlorophenyl)-3-[2-(spiro-substituted piperidin-1'-yl)ethyl]piperidines
1998, Bioorganic and Medicinal Chemistry LettersPharmacological profiles of new orally active nonpeptide tachykinin NK<inf>1</inf> receptor antagonists
1998, European Journal of Pharmacology2 Neurokinin Receptor Antagonists
1998, Progress in Medicinal Chemistry
Copyright © 1994 Published by Elsevier Ltd.